Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in TaxesChange in TaxesOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Change in Accured Expenses (2020 - 2024)

Universe Pharmaceuticals' Change in Accured Expenses history spans 5 years, with the latest figure at $2.7 million for Q1 2024.

  • On a quarterly basis, Change in Accured Expenses rose 26.35% to $2.7 million in Q1 2024 year-over-year; TTM through Mar 2024 was $2.7 million, a 26.35% increase, with the full-year FY2025 number at -$85.4 million, down 171.52% from a year prior.
  • Change in Accured Expenses hit $2.7 million in Q1 2024 for Universe Pharmaceuticals, up from $2.7 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for UPC hit a ceiling of $376.0 billion in Q3 2020 and a floor of $444319.0 in Q3 2021.
  • Historically, Change in Accured Expenses has averaged $53.7 billion across 5 years, with a median of $2.5 million in 2022.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 100.0% in 2021 and later skyrocketed 471.52% in 2022.
  • Tracing UPC's Change in Accured Expenses over 5 years: stood at $376.0 billion in 2020, then tumbled by 100.0% to $444319.0 in 2021, then skyrocketed by 471.52% to $2.5 million in 2022, then grew by 6.79% to $2.7 million in 2023, then increased by 0.53% to $2.7 million in 2024.
  • Business Quant data shows Change in Accured Expenses for UPC at $2.7 million in Q1 2024, $2.7 million in Q3 2023, and $2.2 million in Q1 2023.